Nasdaq · CIK 0001932393
GEHC GE HealthCare Technologies Inc.
Insider trading from SEC Form 4. Last filing 25 d ago. Close $65.74 on Oct 9, 2026, +11% from the 52-week low and -25% from the high.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at GE HealthCare Technologies Inc., scored.
| Score | Side | Insider | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 32Weak | sell | George A. Newcomb Chief Accounting Officer | $185k | 2,000 | -21% | - | |
| 37Weak | sell 2 | Roland Rott CEO, Imaging | $309k | 3,577 | -13% | - | |
| 42Moderate | sell 2 | Philip Rackliffe CEO, AVS | $79k | 900 | -7% | - |
Congressional trades
7 trades in GEHC disclosed by members of Congress under the STOCK Act. All congressional trades.
| Member | Type | Asset | Amount | Traded | Filed |
|---|---|---|---|---|---|
| Alan Armstrong Senate · R-OK | Purchase | GEHC GE HealthCare Technologies Inc. - Common Stock | $1,001 to $15k | Mar 27, 2026 | 116 days after the trade |
| Terri A. Sewell House · D-AL | Sale | GEHC GE HealthCare Technologies Inc. - Common Stock | $1,001 to $15k | Mar 25, 2026 | 27 days after the trade |
| Warren Davidson House · R-OH | Sale | GEHC GE HealthCare Technologies Inc. - Common Stock | $1,001 to $15k | Mar 23, 2026 | 2 days after the trade |
| Austin Scott House · R-GA | Sale | GEHC GE HealthCare Technologies Inc. - Common Stock | $1,001 to $15k | Mar 27, 2025 | 139 days after the trade |
| Robert P. Bresnahan, Jr. House · R-PA | Purchase | GEHC GE HealthCare Technologies Inc. - Common Stock | $1,001 to $15k | May 15, 2025 | 16 days after the trade |
| Robert P. Bresnahan, Jr. House · R-PA | Sale | GEHC GE HealthCare Technologies Inc. - Common Stock | $1,001 to $15k | Apr 8, 2025 | 20 days after the trade |
| Robert P. Bresnahan, Jr. House · R-PA | Purchase | GEHC GE HealthCare Technologies Inc. - Common Stock | $1,001 to $15k | Feb 25, 2025 | 30 days after the trade |
Transactions
The last 74 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | William K Grogan Chief Financial Officer | AGrant or award Common Stock, par value $0.01 per share | +62,256 | $0.00 | $0 | 62,256 | 25 d ago |
| Sep 14, 2026 | William K Grogan Chief Financial Officer | AGrant or award Common Stock, par value $0.01 per share | +12,840 | $0.00 | $0 | 75,096 | 25 d ago |
| Sep 14, 2026 | William K Grogan Chief Financial Officer | AGrant or award Employee Stock Option (right to buy)derivative | +31,877 | $0.00 | $0 | 31,877 | 25 d ago |
| Sep 3, 2026 | Taha Kass-Hout Chief Technology Officer | FTax withholding Common Stock, par value $0.01 per share | -1,502 | $70.56 | $106k | 88,467 | 37 d ago |
| Sep 3, 2026 | Philip Rackliffe CEO, AIS | FTax withholding Common Stock, par value $0.01 per share | -798 | $70.56 | $56k | 41,533 | 37 d ago |
| Sep 3, 2026 | George A. Newcomb Chief Accounting Officer | FTax withholding Common Stock, par value $0.01 per share | -112 | $70.56 | $7,903 | 10,515 | 37 d ago |
| Sep 3, 2026 | Kevin Michael O'Neill CEO, PDx | FTax withholding Common Stock, par value $0.01 per share | -718 | $70.56 | $51k | 32,026 | 37 d ago |
| Sep 3, 2026 | Adam Y Holton Chief People Officer | FTax withholding Common Stock, par value $0.01 per share | -673 | $70.56 | $47k | 19,533 | 37 d ago |
| Sep 3, 2026 | Frank R Jimenez GC & Corporate Secretary | FTax withholding Common Stock, par value $0.01 per share | -1,480 | $70.56 | $104k | 89,321 | 37 d ago |
| Sep 3, 2026 | Catherine Estrampes Chief Commer. & Growth Officer | FTax withholding Common Stock, par value $0.01 per share | -508 | $70.56 | $36k | 23,573 | 37 d ago |
| Sep 3, 2026 | Peter J Arduini President and CEO | FTax withholding Common Stock, par value $0.01 per share | -6,303 | $70.56 | $445k | 241,606 | 37 d ago |
| Sep 1, 2026 | Peter J Arduini President and CEO | FTax withholding Common Stock, par value $0.01 per share | -6,043 | $71.23 | $430k | 253,381 | 38 d ago |
| Sep 1, 2026 | Jeannette Bankes CEO, Patient Care Solutions | FTax withholding Common Stock, par value $0.01 per share | -1,064 | $71.23 | $76k | 37,293 | 38 d ago |
| Sep 1, 2026 | Frank R Jimenez GC & Corporate Secretary | FTax withholding Common Stock, par value $0.01 per share | -1,751 | $71.23 | $125k | 92,181 | 38 d ago |
| Sep 1, 2026 | Adam Y Holton Chief People Officer | FTax withholding Common Stock, par value $0.01 per share | -659 | $71.23 | $47k | 20,206 | 38 d ago |
| Sep 1, 2026 | Taha Kass-Hout Chief Technology Officer | FTax withholding Common Stock, par value $0.01 per share | -1,644 | $71.23 | $117k | 91,265 | 38 d ago |
| Sep 1, 2026 | Philip Rackliffe CEO, AIS | FTax withholding Common Stock, par value $0.01 per share | -290 | $71.23 | $21k | 42,897 | 38 d ago |
| Sep 1, 2026 | Taha Kass-Hout Chief Technology Officer | FTax withholding Common Stock, par value $0.01 per share | -1,296 | $71.23 | $92k | 89,969 | 38 d ago |
| Sep 1, 2026 | Philip Rackliffe CEO, AIS | FTax withholding Common Stock, par value $0.01 per share | -226 | $71.23 | $16k | 42,671 | 38 d ago |
| Sep 1, 2026 | Frank R Jimenez GC & Corporate Secretary | FTax withholding Common Stock, par value $0.01 per share | -1,380 | $71.23 | $98k | 90,801 | 38 d ago |
| Sep 1, 2026 | Peter J Arduini President and CEO | FTax withholding Common Stock, par value $0.01 per share | -5,472 | $71.23 | $390k | 247,909 | 38 d ago |
| Sep 1, 2026 | Philip Rackliffe CEO, AIS | FTax withholding Common Stock, par value $0.01 per share | -340 | $71.23 | $24k | 42,331 | 38 d ago |
| Mar 3, 2025 | Kenneth R. Stacherski Ch. Supply Chain & Serv. Ofc. | AGrant or award Common Stock, par value $0.01 per share | +5,060 | $0.00 | $0 | 31,671 | Mar 5, 2025 |
| Mar 3, 2025 | Philip Rackliffe CEO, AVS | AGrant or award Common Stock, par value $0.01 per share | +4,916 | $0.00 | $0 | 17,473 | Mar 5, 2025 |
| Mar 3, 2025 | James Saccaro Chief Financial Officer | AGrant or award Common Stock, par value $0.01 per share | +11,278 | $0.00 | $0 | 71,544 | Mar 5, 2025 |
| Mar 3, 2025 | Roland Rott CEO, Imaging | AGrant or award Common Stock, par value $0.01 per share | +7,952 | $0.00 | $0 | 30,235 | Mar 5, 2025 |
| Mar 3, 2025 | Frank R Jimenez GC & Corporate Secretary | AGrant or award Common Stock, par value $0.01 per share | +10,121 | $0.00 | $0 | 71,572 | Mar 5, 2025 |
| Mar 1, 2025 | Kevin Michael O'Neill CEO, PDx | FTax withholding Common Stock, par value $0.01 per share | -1,521 | $87.35 | $133k | 18,354 | Mar 5, 2025 |
| Mar 3, 2025 | Adam Y Holton Chief People Officer | AGrant or award Common Stock, par value $0.01 per share | +4,337 | $0.00 | $0 | 17,232 | Mar 5, 2025 |
| Mar 1, 2025 | Thomas J. Westrick CEO, Patient Care Solutions | FTax withholding Common Stock, par value $0.01 per share | -949 | $87.35 | $83k | 15,320 | Mar 5, 2025 |
| Mar 3, 2025 | Taha Kass-Hout Chief Technology Officer | AGrant or award Common Stock, par value $0.01 per share | +11,567 | $0.00 | $0 | 68,272 | Mar 5, 2025 |
| Mar 1, 2025 | George A. Newcomb Chief Accounting Officer | FTax withholding Common Stock, par value $0.01 per share | -342 | $87.35 | $30k | 6,549 | Mar 5, 2025 |
| Mar 3, 2025 | Peter J Arduini President and CEO | AGrant or award Common Stock, par value $0.01 per share | +41,931 | $0.00 | $0 | 179,228 | Mar 5, 2025 |
| Mar 3, 2025 | George A. Newcomb Chief Accounting Officer | AGrant or award Common Stock, par value $0.01 per share | +1,156 | $0.00 | $0 | 7,705 | Mar 5, 2025 |
| Mar 3, 2025 | Thomas J. Westrick CEO, Patient Care Solutions | AGrant or award Common Stock, par value $0.01 per share | +3,181 | $0.00 | $0 | 18,501 | Mar 5, 2025 |
| Mar 3, 2025 | Kevin Michael O'Neill CEO, PDx | AGrant or award Common Stock, par value $0.01 per share | +4,626 | $0.00 | $0 | 22,980 | Mar 5, 2025 |
| Mar 3, 2025 | Kenneth R. Stacherski Ch. Supply Chain & Serv. Ofc. | AGrant or award Employee Stock Option (right to buy)derivative | +14,472 | $0.00 | $0 | 14,472 | Mar 5, 2025 |
| Mar 3, 2025 | James Saccaro Chief Financial Officer | AGrant or award Employee Stock Option (right to buy)derivative | +32,252 | $0.00 | $0 | 32,252 | Mar 5, 2025 |
| Mar 3, 2025 | Philip Rackliffe CEO, AVS | AGrant or award Employee Stock Option (right to buy)derivative | +14,058 | $0.00 | $0 | 14,058 | Mar 5, 2025 |
| Mar 3, 2025 | Peter J Arduini President and CEO | AGrant or award Employee Stock Option (right to buy)derivative | +119,913 | $0.00 | $0 | 119,913 | Mar 5, 2025 |
| Mar 3, 2025 | Taha Kass-Hout Chief Technology Officer | AGrant or award Employee Stock Option (right to buy)derivative | +33,079 | $0.00 | $0 | 33,079 | Mar 5, 2025 |
| Mar 3, 2025 | Adam Y Holton Chief People Officer | AGrant or award Employee Stock Option (right to buy)derivative | +12,404 | $0.00 | $0 | 12,404 | Mar 5, 2025 |
| Mar 3, 2025 | Frank R Jimenez GC & Corporate Secretary | AGrant or award Employee Stock Option (right to buy)derivative | +28,944 | $0.00 | $0 | 28,944 | Mar 5, 2025 |
| Mar 3, 2025 | Roland Rott CEO, Imaging | AGrant or award Employee Stock Option (right to buy)derivative | +22,742 | $0.00 | $0 | 22,742 | Mar 5, 2025 |
| Mar 3, 2025 | Thomas J. Westrick CEO, Patient Care Solutions | AGrant or award Employee Stock Option (right to buy)derivative | +9,096 | $0.00 | $0 | 9,096 | Mar 5, 2025 |
| Mar 3, 2025 | George A. Newcomb Chief Accounting Officer | AGrant or award Employee Stock Option (right to buy)derivative | +3,307 | $0.00 | $0 | 3,307 | Mar 5, 2025 |
| Mar 3, 2025 | Kevin Michael O'Neill CEO, PDx | AGrant or award Employee Stock Option (right to buy)derivative | +13,231 | $0.00 | $0 | 13,231 | Mar 5, 2025 |
| Mar 1, 2025 | Peter J Arduini President and CEO | FTax withholding Common Stock, par value $0.01 per share | -4,507 | $87.35 | $394k | 167,115 | Mar 4, 2025 |
| Mar 1, 2025 | George A. Newcomb Chief Accounting Officer | FTax withholding Common Stock, par value $0.01 per share | -571 | $87.35 | $50k | 6,891 | Mar 4, 2025 |
| Mar 1, 2025 | Roland Rott CEO, Imaging | FTax withholding Common Stock, par value $0.01 per share | -1,457 | $87.35 | $127k | 22,283 | Mar 4, 2025 |
| Mar 1, 2025 | Frank R Jimenez GC & Corporate Secretary | FTax withholding Common Stock, par value $0.01 per share | -6,826 | $87.35 | $596k | 66,292 | Mar 4, 2025 |
| Mar 1, 2025 | Kevin Michael O'Neill CEO, PDx | FTax withholding Common Stock, par value $0.01 per share | -2,140 | $87.35 | $187k | 19,875 | Mar 4, 2025 |
| Mar 1, 2025 | Thomas J. Westrick CEO, Patient Care Solutions | FTax withholding Common Stock, par value $0.01 per share | -873 | $87.35 | $76k | 16,269 | Mar 4, 2025 |
| Mar 1, 2025 | Peter J Arduini President and CEO | FTax withholding Common Stock, par value $0.01 per share | -29,818 | $87.35 | $2.6M | 137,297 | Mar 4, 2025 |
| Mar 1, 2025 | Frank R Jimenez GC & Corporate Secretary | FTax withholding Common Stock, par value $0.01 per share | -4,841 | $87.35 | $423k | 61,451 | Mar 4, 2025 |
| Feb 18, 2025 | George A. Newcomb Chief Accounting Officer | SOpen-market sale Common Stock, par value $0.01 per share | -2,000 | $92.54 | $185k | 7,462 | Feb 19, 2025 |
| Feb 6, 2025 | Peter J Arduini President and CEO | AGrant or award Common Stock, par value $0.01 per share | +67,487 | $0.00 | $0 | 171,622 | Feb 10, 2025 |
| Feb 1, 2025 | Peter J Arduini President and CEO | FTax withholding Common Stock, par value $0.01 per share | -3,206 | $88.30 | $283k | 104,135 | Feb 4, 2025 |
| Feb 1, 2025 | Taha Kass-Hout Chief Technology Officer | FTax withholding Common Stock, par value $0.01 per share | -875 | $88.30 | $77k | 64,827 | Feb 4, 2025 |
| Feb 1, 2025 | Kevin Michael O'Neill CEO, PDx | FTax withholding Common Stock, par value $0.01 per share | -462 | $88.30 | $41k | 22,015 | Feb 4, 2025 |
| Feb 1, 2025 | George A. Newcomb Chief Accounting Officer | FTax withholding Common Stock, par value $0.01 per share | -108 | $88.30 | $9,536 | 9,462 | Feb 4, 2025 |
| Feb 1, 2025 | Kenneth R. Stacherski Ch. Supply Chain & Serv. Ofc. | FTax withholding Common Stock, par value $0.01 per share | -444 | $88.30 | $39k | 26,611 | Feb 4, 2025 |
| Feb 1, 2025 | Philip Rackliffe CEO, AVS | FTax withholding Common Stock, par value $0.01 per share | -158 | $88.30 | $14k | 12,557 | Feb 4, 2025 |
| Feb 1, 2025 | Frank R Jimenez GC & Corporate Secretary | FTax withholding Common Stock, par value $0.01 per share | -979 | $88.30 | $86k | 73,118 | Feb 4, 2025 |
| Feb 1, 2025 | Thomas J. Westrick CEO, Patient Care Solutions | FTax withholding Common Stock, par value $0.01 per share | -367 | $88.30 | $32k | 17,142 | Feb 4, 2025 |
| Feb 1, 2025 | Roland Rott CEO, Imaging | FTax withholding Common Stock, par value $0.01 per share | -558 | $88.30 | $49k | 23,740 | Feb 4, 2025 |
| Feb 1, 2025 | James Saccaro Chief Financial Officer | FTax withholding Common Stock, par value $0.01 per share | -934 | $88.30 | $82k | 60,266 | Feb 4, 2025 |
| Feb 2, 2025 | Taha Kass-Hout Chief Technology Officer | FTax withholding Common Stock, par value $0.01 per share | -8,122 | $88.30 | $717k | 56,705 | Feb 4, 2025 |
| Nov 5, 2024 | Roland Rott CEO, Imaging | MOption exercise Common Stock, par value $0.01 per share | +13,275 | $40.40 | $536k | 37,573 | Nov 6, 2024 |
| Nov 5, 2024 | Roland Rott CEO, Imaging | FTax withholding Common Stock, par value $0.01 per share | -9,698 | $87.65 | $850k | 27,875 | Nov 6, 2024 |
| Nov 6, 2024 | Roland Rott CEO, Imaging | SOpen-market sale Common Stock, par value $0.01 per share | -3,577 | $86.48 | $309k | 24,298 | Nov 6, 2024 |
| Nov 5, 2024 | Roland Rott CEO, Imaging | MOption exercise Employee Stock Option (right to buy)derivative | -13,275 | $0.00 | $0 | 0 | Nov 6, 2024 |
| Nov 5, 2024 | Philip Rackliffe CEO, AVS | SOpen-market sale Common Stock, par value $0.01 per share | -900 | $87.63 | $79k | 12,715 | Nov 5, 2024 |
| Nov 1, 2024 | Kenneth R. Stacherski Ch. Supply Chain & Serv. Ofc. | FTax withholding Common Stock, par value $0.01 per share | -11,028 | $87.35 | $963k | 27,055 | Nov 5, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Peter J ArduiniPresident and CEO
- Jeannette BankesCEO, Patient Care Solutions
- Catherine EstrampesChief Commer. & Growth Officer
- William K GroganChief Financial Officer
- Adam Y HoltonChief People Officer
- Frank R JimenezGC & Corporate Secretary
- Taha Kass-HoutChief Technology Officer
- George A. NewcombChief Accounting Officer
- Kevin Michael O'NeillCEO, PDx
- Philip RackliffeCEO, AIS
- Roland RottCEO, Imaging
- James SaccaroChief Financial Officer
- Kenneth R. StacherskiCh. Supply Chain & Serv. Ofc.
- Thomas J. WestrickCEO, Patient Care Solutions
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.